Results: Several overlapping pepetides showed positve binding with 15 patients with SARS, and five peptides seemed to be common epitope peptides. They are MKY1 (Gln-Len-Len-Gln-Gln-Trp-Asn-Len-Val), MKY2 (Trp-Ph-Asn-Pro-Glu-Thr-Asn-Ile), MKY3 (Val-Thr-Arg-Pro-Leu-Met-Glu-Ser), MKY4 (Ser-Tyr-Tyr-Lys-Leu-Gly-Ala), MKY5 (Val-Gly-Thr-Asp-Ser-Gly-Phe-Ala-Ala-Tyr), sera did not react with a control peptides, and normal sera also did not react with pepetides of human being' SARS Coronavirus M protein. Elaboration of mucosal vaccines involving biodegradable polymer complexes is a topical problem. These polymers are capable of protecting the virus from acid gastric medium and releasing the virus in weakly alkaline intestinal medium. In addition, the majority of these polymers are capable of intensifying the immune response to the antigen introduced. The purpose of work was the choice of the polymer system for effective viral vaccine development. We used the following methods: microgranulation into a polymer matrix through atomization of the viral material dissolved in polymeric solvent into a liquid nitrogen, microencapsulation through forming the coating on a drop containing the viral material, while contacting with solution of the forming material, micro-and nanoencapsulation by cryocoacervation method.
coacervation of viral suspensions in hydrophobic liquids into a gelatin envelope. The methods of transmission electron microscopy, atomic force microscopy, freeze-fractography, determination of specific activity and immunogenicity were used to control of viral preparations. According to our data, the most perspective method was the cryocoacervation. The method proposed allows for production of spherical or irregular-shaped particles with size of 0.1-10 μm. This method is universal and may be applied for microand nanoencapsulation of different viruses and for design of various viral vaccines. International PCT patent application was submitted and registered as PCT/Ru/02/00465.
PP-181 A novel 2-tailed CUSUM control-chart for evaluating new therapies: hypertonic-saline in bronchiolitis compared to nebulized adrenaline
Neeraj Gupta *, Jacob Puliyel, Ashutosh Shrivastava, Samiksha Manchanda. St. Stephen's Hospital Background: Randomized control trials are difficult to perform, expensive and involve thorny ethical issues. CUSUM is a continuous process of monitoring, used in industry that allows early detection of deviations from the norm. We used CUSUM to study 3% saline nebulization (3%SN), a new treatment for bronchiolitis. The response rate to standard therapy with nebulized adrenaline (STNA) provided parameters within which 3% SN was evaluated. Methods: Children 2 months to 2 years admitted with first episode acute bronchiolitis were recruited. In phase-one, STNA was studied looking for improvement or deterioration on Downes respiratory-distress-score. Downes score at admission could improve or deteriorate during course of treatment. This provided the stopping rule and also the thresholds beyond which 3% SN can be considered as yielding more improvement than standard therapy. A total of 35 children were enrolled in phase 1 and 28 received 3% SN in phase 2. Results: The probability of deterioration with 3% SN was half (1:14) compared to STNA (1:7) and 89.3% showed improvement compared to 82.8%. Plotting these in sequence on the CUSUM-chart allowed for continued use of the new therapy and confidence that it was not inferior to standard therapy. Conclusion: Changes in score with treatment allowed the CUSUMgraph to depict if the new intervention produced more adverse events (crossing stopping threshold) or was significantly better. We found that 3% SN children had less deterioration than STNA and there was a trend for more improvement. CUSUM, as we have employed it, has potential in numerous medical evaluations.
PP-182 Systematic study the clinic characters of a local measles outbreak in East China
Tiansheng Xie * ,1 , Nanping Wu 1 , Airong Hu 2 , Xiaoyue Liang 2 . Results: 216 patients' infectious spectrum was like a spindle, the infants and adults parts of the infectious spectrum reach a total of 81.48%. The clinical symptoms remain relatively typical. Different groups showed their own clinical manifestations, The major features of the infants group are cough and Korotkoff plaques, in this group, the MV-IgM positive rate is the highest, 83.67% of the infants have complications. The subjects of the children group showed the major symptoms as catarrhal, 70% of which with complications. Hepatic function in the adult group is significantly abnormal. In our 78 cases adult patients, the FCM results suggest CD4 cell count and CD4/CD8 decreased significantly, and CD8 increased significantly, also CD4 + CD45RA + was significantly lower than control (p<0.05), and CD8 + CD45RO + was significantly higher than control group (p<0.05).
Conclusion:
The use of measles vaccine greatly change its infectious spectrum. The emergence of new clinical characteristics give us challenges for its prevention and control. At the same time, further study of the measles infectious cellular immunity mechanism still needed.
PP-183 Prevalence of pneumonia cases during the Hajj season
Atif Asghar * ,1 , Ahmad Ashshi 1 , Aiman Momenah 1 , Tariq Zafar 1 , Esam Azhar 2 , Syed Bukhari 3 . 1 Umm Al-Qura University; 2 King Abdulaziz University; 3 Herra Genaral Hospital
Background: The congregation of so many people during Hajj seasons from different parts of the world in unavoidably overcrowded conditions within a confined area for a defined period of time presents many public health challenges, and health risks are greatly increased. One of the main health problems correlated with Hajj crowding is pneumonia due to its ease of transmission by air droplets. Method: A total of 92 suspected patients with pneumonia from the three main tertiary hospitals in Makkah were investigated during the 2005 Hajj season. Sputum and serum samples were collected and investigated for possible presence of typical or atypical causative agents using the standard identification techniques. Results: Clinically, most of the patients came with typical pneumonia symptoms. More than 60% of the patients were above 60 years old and 58% were men. The most frequent isolates were Candida spp, (27%) followed by Pseudomonas aeruginosa (20.7%) and Legionella pneumophila (14.1%). Interestingly, more than causative pathogen were isolated in 15 patients (16.3%). A 55% of patients were diabetic. Conclusion: Clinicians should be aware that typical pneumonia treatment regimes may not work well during the Hajj season due to the wide variety of isolated organisms. This necessitates taking a sputum sample before starting treatment for identification and sensitivity testing. Since most of the patients are above 60 years, a special concern should be given to this age group which include; immunization, avoiding crowding and using a facial masks to reduce the chance of infection.
